甲氧氯普胺在分化型甲状腺癌患者随访中的应用

Application of metoclopramide in follow-up of patients with differentiated thyroid carcinoma

对分化型甲状腺癌（DTC）患者随访时，需停用左旋甲状腺素（L-T4）4—6周，检测血清甲状腺球蛋白及^131I-全身显像，以利于早期发现DTC病灶复发和转移。本研究将甲氧氯普胺（MCP，胃复安）用于随访的DTC患者，结果显示MCP没有明显升高TSH，其临床应用有待于进一步研究。

During following-up the patients with differentiated thyroid carcinoma （DTC）, it is necessary that L-T4 has to be held for 4-6 weeks for determining serum thyroglobulin level and performing ^131I whole body scann, so that recurrence and metastasis of DTC may be discovered early. In this study, the metoclopramide （MCP） was applied in DTC patients during following up and the results showed that serum TSH level was not changed by MCP and the clinical application of MCP should be subjected to further investigation.